Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Firms / Jeito Capital Sas

Jeito Capital Sas

Institutional venture firmParisjeito.lifeSEC venture capital fund adviserone firm, 2 filing advisers

This firm files as 2 advisers on jeito.life: Jeito Capital LLC. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.

Jeito est un fonds biotechnologique de nouvelle génération dont l'approche est axée sur les avantages pour les patients et qui se concentre à la fois sur le financement d'innovations médicales révolutionnaires et sur la promotion d'un impact sociétal positif.

venture manager, reported GAV $331M across 2 vehicles

Importance
21
moderate
Active deployment
29
moderate
Emerging
0
low
Completeness
69
high
Freshness
100
high
Research priority
11
low
Identity and regulatory footprint
Headquarters
Paris, Franceadviserinfo.sec.gov
Office address
2-4 RUE PILLET-WILL, Paris, 75009adviserinfo.sec.gov
Business phone
0033 603354757adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Apr 19, 2024
Private funds reported
2 (2 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$331Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
Kohara (Ordinary Shareholder), B; RTB Invest (Preferred Shareholder), E
business phone
0033 603354757adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
Sectors
biotech
Stages
not stated or not yet read
Geography
europe
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 1
Funds and vehicles
2 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
Jeito II S.L.P.Fund2024 adv first reportedEarly deployment$0
Apr 19, 2024
12unknownunknown
Jeito S.L.P.FundunknownUnknown$331M
Apr 19, 2024
50unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
12 current, 0 departed
Ivana Trivunovic
Earlier in her career, she served as a Scientific Advisor to several private biotechnology companies.
Board or advisory
Oliver Ricome
Operating Partner, Medical Strategy Samit
Operating partner
Mehdi Ainouche
Mehdi Ainouche, PharmD, is Partner at Jeito Capital.
Partner
Charlotte Formont
Charlotte joined Jeito in 2022 as an Associate Counsel, and progressed to Senior Legal Counsel in October 2024.
Platform and operations
Evaldo Bifulco Jr.
Evaldo Bifulco is Head of Sustainability, Compliance & Risk (RCCI) at Jeito.
Platform and operations
Henri Mazeau
Henri is a Legal Counsel at Jeito Capital.
Platform and operations
Investments on record
1 edges, 1 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
theirportfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
1 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
  1. Mar 22, 2024
    Jeito II S.L.P. first reported on Form ADV by Jeito Capital Sas (Venture Capital Fund)
  2. Sep 15, 2021
    Jeito Capital Sas first filed Form ADV (ERA, venture capital fund adviser exemption)
  3. Sep 15, 2021
    Jeito S.L.P. first reported on Form ADV by Jeito Capital Sas (Venture Capital Fund), GAV $513,380,000
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $331M across 2 vehicles
Evidence
32 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedventure_capital_fund_adviserApr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserApr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2021-09-15Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-04-19Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone0033 603354757Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://www.jeito.life/contact/
contact page linked from the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionJeito est un fonds biotechnologique de nouvelle génération dont l'approche est axée sur les avantages pour les patients et qui se concentre à la fois sur le financement d'innovations médicales révolutionnaires et sur la promotion d'un impact sociétal positif.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionJeito est un fonds biotechnologique de nouvelle génération dont l'approche est axée sur les avantages pour les patients et qui se concentre à la fois sur le financement d'innovations médicales révolutionnaires et sur la promotion d'un impact sociétal positif.
meta description
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersParis, FranceApr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address2-4 RUE PILLET-WILL, Paris, 75009Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formOther (specify)Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://www.jeito.life/en/portfolio/
1 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://www.jeito.life/en/portfolio/
1 entries read
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported2Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$331MApr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyeurope
geography words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyeurope
geography words on the home page
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorsbiotech
sector words on the home page
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://www.jeito.life/en/team/
7 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://www.jeito.life/en/team/
7 name/title pairs read
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported2Apr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttp://www.jeito.lifeApr 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleUn effort axé sur les avantages pour le patient
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleUn effort axé sur les avantages pour le patient
title tag
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)